Recent Posts

1. 

   It's the first drug shown to slow Alzheimer's. Why is it off to a slow start? | AP News

   Dumbass ABLs leading the charge

   Eisai

   anonymous

   Apr 25, 2024 at 1:26 PM

2. 

   Sell Otezla and Keep Sotyktu?

   18 months in and we are selling $34millon in the U.S. for the quarter. Otezla has been selling $170million every MONTH since we sold it off in favor of Sotyktu. We are so far behind on the P&L that we now need to ramp up peak years sales to...

   Bristol-Myers Squibb

   anonymous

   Apr 25, 2024 at 1:23 PM

3. 

   How to destroy field medical

   Listen honey, we gotta get out there and hustle! This ain't no desk job. We gotta be with the folks we're helping, face-to-face. That's how you get things done, you understand? You gotta put in the miles to make a difference If this ain't your...

   Genentech

   anonymous

   Apr 25, 2024 at 1:21 PM

4. 

   Elevar

   Data is meh. And no stock. Pass.

   Biotech Startups

   anonymous

   Apr 25, 2024 at 1:16 PM

5. 

   The stock price

   Do something? Leaders have done plenty! For instance, they changed our logo and they moved the home office to a different part of NYC. A month or two ago Industry rags declared that marketing had changed ad agencies. The synergistic effect and...

   Pfizer

   anonymous

   Apr 25, 2024 at 1:08 PM

6. 

   Please cancel team trips

   Yaaaaaas!!!!!!! So totes………like whatevs!!

   Astellas

   anonymous

   Apr 25, 2024 at 1:06 PM

7. 

   Conference calls

   Here's the script for the next investor's call; "Blah blah blah Blah blah blah market headwinds Blah blah blah, Blah blah blah Blah blah blah, Blah blah blah, another dilution,Blah blah blah, clinical trial data from 2 years ago shows,Blah blah...

   Lexicon Pharmaceuticals

   anonymous

   Apr 25, 2024 at 12:59 PM

8. + Show More